NM_000815.5:c.330T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000815.5(GABRD):c.330T>C(p.Gly110Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.633 in 1,612,716 control chromosomes in the GnomAD database, including 327,885 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 33159 hom., cov: 34)
Exomes 𝑓: 0.63 ( 294726 hom. )
Consequence
GABRD
NM_000815.5 synonymous
NM_000815.5 synonymous
Scores
7
Clinical Significance
Conservation
PhyloP100: -1.22
Publications
21 publications found
Genes affected
GABRD (HGNC:4084): (gamma-aminobutyric acid type A receptor subunit delta) Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. The GABA-A receptor is generally pentameric and there are five types of subunits: alpha, beta, gamma, delta, and rho. This gene encodes the delta subunit. Mutations in this gene have been associated with susceptibility to generalized epilepsy with febrile seizures, type 5. Alternatively spliced transcript variants have been described for this gene, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
GABRD Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics, ClinGen
- epilepsyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- epilepsy, idiopathic generalized, susceptibility to, 10Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=9.98378E-7).
BP6
Variant 1-2025598-T-C is Benign according to our data. Variant chr1-2025598-T-C is described in ClinVar as Benign. ClinVar VariationId is 256823.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.721 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABRD | NM_000815.5 | c.330T>C | p.Gly110Gly | synonymous_variant | Exon 4 of 9 | ENST00000378585.7 | NP_000806.2 | |
| GABRD | XM_017000936.2 | c.1035T>C | p.Gly345Gly | synonymous_variant | Exon 3 of 8 | XP_016856425.1 | ||
| GABRD | XM_011541194.4 | c.369T>C | p.Gly123Gly | synonymous_variant | Exon 4 of 9 | XP_011539496.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.655 AC: 99494AN: 151996Hom.: 33171 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
99494
AN:
151996
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.588 AC: 147340AN: 250576 AF XY: 0.589 show subpopulations
GnomAD2 exomes
AF:
AC:
147340
AN:
250576
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.630 AC: 920909AN: 1460604Hom.: 294726 Cov.: 57 AF XY: 0.627 AC XY: 455681AN XY: 726602 show subpopulations
GnomAD4 exome
AF:
AC:
920909
AN:
1460604
Hom.:
Cov.:
57
AF XY:
AC XY:
455681
AN XY:
726602
show subpopulations
African (AFR)
AF:
AC:
24481
AN:
33476
American (AMR)
AF:
AC:
21773
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
18198
AN:
26132
East Asian (EAS)
AF:
AC:
14303
AN:
39696
South Asian (SAS)
AF:
AC:
40907
AN:
86256
European-Finnish (FIN)
AF:
AC:
33484
AN:
52304
Middle Eastern (MID)
AF:
AC:
4084
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
725697
AN:
1111880
Other (OTH)
AF:
AC:
37982
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
20647
41294
61942
82589
103236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18814
37628
56442
75256
94070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.654 AC: 99507AN: 152112Hom.: 33159 Cov.: 34 AF XY: 0.647 AC XY: 48096AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
99507
AN:
152112
Hom.:
Cov.:
34
AF XY:
AC XY:
48096
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
30232
AN:
41514
American (AMR)
AF:
AC:
9158
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2469
AN:
3470
East Asian (EAS)
AF:
AC:
1757
AN:
5160
South Asian (SAS)
AF:
AC:
2235
AN:
4818
European-Finnish (FIN)
AF:
AC:
6780
AN:
10584
Middle Eastern (MID)
AF:
AC:
215
AN:
292
European-Non Finnish (NFE)
AF:
AC:
44549
AN:
67960
Other (OTH)
AF:
AC:
1390
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1812
3624
5435
7247
9059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2477
ALSPAC
AF:
AC:
2516
ESP6500AA
AF:
AC:
3220
ESP6500EA
AF:
AC:
5680
ExAC
AF:
AC:
71860
Asia WGS
AF:
AC:
1444
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 06, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epilepsy, idiopathic generalized, susceptibility to, 10 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
PhyloP100
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.